Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huizi Sun

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
EMBO Molecular Medicine|July 31, 2024
Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancerHong Wang, Huizi Sun, Jie Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2025
Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancerHong Wang, Jie Huang, Zhenhua Zhang, et al.
Cell Death Discovery|December 22, 2025
FGF1-FGFR2 axis regulated by nuclear receptor RORγ represents an effective strategy in intrahepatic cholangiocarcinomaZhanfeng Gu, Xiaojuan Wang, Hong Wang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
EMBO Molecular Medicine|July 31, 2024
Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancerHong Wang, Huizi Sun, Jie Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2025
Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancerHong Wang, Jie Huang, Zhenhua Zhang, et al.
Cell Death Discovery|December 22, 2025
FGF1-FGFR2 axis regulated by nuclear receptor RORγ represents an effective strategy in intrahepatic cholangiocarcinomaZhanfeng Gu, Xiaojuan Wang, Hong Wang, et al.
Pageof 2